Stock Alerts

A reminder today of why Jubak Pick Incyte has been so weak lately

Time to buy Incyte on the biotech dip

Maybe you didn't even know there was a biotech dip. If all you've been following in the sector is a stock like Nektar Therapeutics (NKTR), a Jubak Picks member (and the call options are a holding in my Volatility Portfolio), you're likely to respond "What dip?" Nektar...